Ultrasound-guided Deep Versus Superficial Continuous Serratus Anterior Plane Block for Pain Management in Patients With Multiple Rib Fractures
Multiple Rib Fractures, Pain, Acute, Serratus Anterior Plane Block
About this trial
This is an interventional treatment trial for Multiple Rib Fractures focused on measuring serratus anterior plane block, multiple rib fractures
Eligibility Criteria
Inclusion Criteria:
- Adult patients of either sex, having three or more unilateral fracture ribs and admitted to the trauma ICU, Rib fractures were confirmed by X-ray and CT scan reads.
Exclusion Criteria:
- significant head injury and unconsciousness (GCS less than 14)
- Patients with significant pain from other injuries
- pathological obesity (body mass index ≥35)
- history of drug allergy local anesthetics
- local infection at the injection site
- inability to obtain consent from patient or surrogate, and patient refusal
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Continuous Deep Serratus Anterior Plane Block group
Continuous Superficial Serratus Anterior Plane Block group
at the level of the fifth rib in the mid-axillary line. After anaesthetizing the skin with 2 mL of lidocaine 2%, an 18-gauge Touhy needle was introduced in-plane, under direct visualization, to the plane immediately deep to the serratus anterior muscle. After negative aspiration, 35 mL of bupivacaine 0.25% will be injected. Afterwards, a 20-gauge peripheral nerve catheter will be threaded into the space. then bupivacaine 0.125% infusion at a rate of 5 ml/h by an Infusion Syringe Pump will be started.
at the level of the fifth rib in the mid-axillary line. After anaesthetizing the skin with 2 mL of lidocaine 2%, an 18-gauge Touhy needle was introduced in-plane, under direct visualization, to the plane immediately superficial to the serratus anterior muscle. After negative aspiration, 35 mL of bupivacaine 0.25% will be injected. Afterwards, a 20-gauge peripheral nerve catheter will be threaded into the space. then bupivacaine 0.125% infusion at a rate of 5 ml/h by an Infusion Syringe Pump will be started.